1 mg semaglutide equivalent tirzepatide Switching to Tirzepatide vs Semaglutide: Key Differences

11674344 and U1532260) and the Key Research Program of Frontier Sciences, CAS (Grant NO

Company Overview 15.3.3.2

Delays beyond four days warrant provider consultation before re-dosing

As the method of delivery is subcutaneous injection, it may, in rare instances, cause minor injection-related side effects such as [2]: Itching at or around the injection site Swelling General discomfort However, these side effects are rare and were not reported at a rate deemed statistically significant during any phase 2 or 3 clinical trials involving PT-141

The study documented significant improvements in cardiometabolic risk factors including blood pressure, lipids, and glycemic parameters

PMID: 26311425